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Embryonic stem cells (ESCs) are pluripotent, self-
renewing, and have the ability to reprogram differen-
tiated cell types to pluripotency upon cellular fusion.
Polycomb-group (PcG) proteins are important for
restraining the inappropriate expression of lineage-
specifying factors in ESCs. To investigate whether
PcG proteins are required for establishing, rather
thanmaintaining, the pluripotent state, we compared
the ability of wild-type, PRC1-, and PRC2-depleted
ESCs to reprogram human lymphocytes. We show
that ESCs lacking either PRC1 or PRC2 are unable
to successfully reprogram B cells toward pluripo-
tency. This defect is a direct consequence of the
lack of PcG activity because it could be efficiently
rescued by reconstituting PRC2 activity in PRC2-
deficient ESCs. Surprisingly, the failure of PRC2-defi-
cient ESCs to reprogram somatic cells is functionally
dominant, demonstrating a critical requirement for
PcG proteins in the chromatin-remodeling events
required for the direct conversion of differentiated
cells toward pluripotency.
INTRODUCTION
PcG proteins were originally identified in Drosophila mela-
nogaster where they comprise multiprotein complexes required
for maintaining the transcriptional silencing of a subset of
repressed genes (reviewed in Ringrose and Paro, 2004). In
recent years the biochemical properties of different Polycomb
repressor complexes (PRCs) have been clarified in mammals
and invertebrates, as has their genome-wide distribution (Boyer
et al., 2006; Lee et al., 2006; Schwartz et al., 2006). This provided
valuable insights into the mechanisms by which they repress
transcription and convey cellular memory. Two main repressor
complexes, PRC1 and PRC2, with different catalytic properties
and core components have been identified. In mammals PRC2activity depends on three core subunits, embryonic ectoderm
development (Eed), suppressor of Zeste 12 (Suz12) and the
SET domain-containing protein Enhancer of Zeste homolog 2
(Ezh2) that catalyzes histone H3 methylation at lysine 27
(reviewed in Simon and Kingston, 2009). PRC2-mediated
H3K27me3 provides a docking site for PRC1 (Min et al., 2003),
a multiprotein complex thought to be a direct executor of
silencing. It contains four generic core components (Ring1A/
Ring1B, Bmi1/Mel18, Ph1/2, and Pc1/2/3), and catalyzes his-
tone H2A mono-ubiquitination of lysine 119 (reviewed in Simon
and Kingston, 2009). PRC1-mediated silencing probably oper-
ates through a variety of mechanisms and there is evidence
supporting PRC1 in the blocking of transcriptional elongation
of RNA Polymerase II engaged at target sites (Stock et al.,
2007), as well as in directing chromatin compaction (Francis
et al., 2004). Studies in Drosophila melanogaster have also sug-
gested that O-linked glycosylation, mediated by the PcG protein
Sxc may also have a significant role in Polycomb repression
(Gambetta et al., 2009; Sinclair et al., 2009).
We do not know the complete repertoire of roles played by
PcG proteins in mammalian development. In human and mouse
ESCs, PRC1 and PRC2 localize to the promoters of a subset of
repressed genes encoding transcription factors required for
specification later during development. These genes contain
overlapping binding sites for the pluripotency-associated factors
Oct4, Sox2, Nanog, and Sall4 within their promoters (Boyer et al.,
2005, 2006; Lee et al., 2006; Yang et al., 2008) and are enriched
for both histone H3K4me3 and H3K27me3 (Azuara et al., 2006;
Bernstein et al., 2006). Withdrawal of PRC1 or PRC2 activity
from mouse ESCs results in global gene derepression of these
target genes (Azuara et al., 2006; Boyer et al., 2006; Jorgensen
et al., 2006; Lee et al., 2006) and unscheduled differentiation
(Boyer et al., 2006; Endoh et al., 2008), consistent with PRCs
being important for maintaining pluripotency. Furthermore,
Ezh2-deficient embryos die early in gestation and null blasto-
cysts fail to generate ESC lines (O’Carroll et al., 2001), so
PRC2 may also be critical for establishing pluripotency. To
investigate this, we have taken advantage of the documented
capacity of ESCs to directly reprogram differentiated somatic
cells to pluripotency in experimental heterokaryons (Pereira
and Fisher, 2009; Pereira et al., 2008). Previous studies withCell Stem Cell 6, 547–556, June 4, 2010 ª2010 Elsevier Inc. 547
Figure 1. Heterokaryon Reprogramming of
Human B Lymphocytes to Pluripotency by
Mouse ESCs, ECCs, and EGCs but Not
ESCs Lacking either Eed or Suz12
(A) Schematic representation of the strategy for
generating interspecies heterokaryons between
human B lymphocytes and mouse ESCs.
(B) Reprogramming was evaluated by measuring
the induction of human embryonic genes (OCT4,
NANOG, CRIPTO, DNMT3B, SOX2, TLE1, TERT,
and REX1) from human-derived nuclei, via qRT-
PCR and human gene-specific primers, 3 days
after cell fusion. The reprogramming potential of
mouse embryonic stem cells (ESCs, OS25 and
E14tg2A cell lines, black bars), embryonic carci-
noma cells (ECCs, F9 and P19 cell lines, dark
gray bars), and embryonic germ cells (EGCs,
19G and 23G cell lines, light gray bars) is shown.
Error bars indicate the SD of three independent
experiments.
(C) qRT-PCR analysis of heterokaryons generated
between human B lymphocytes and mouse ESCs
knockout for the PRC2 members Eed and Suz12
(white bars), Jarid2, Dnmt1, Dnmt3a/b, Mll, G9a,
and Dicer (black bars). Data were normalized to
human GAPDH expression. Error bars indicate
the SD of 2–3 independent experiments.
(D) Alkaline phosphatase staining of hybrid colo-
nies obtained from fusions of puromycin-resistant
mouse B cells with either Eed-deficient (Eed/) or
wild-type (Eed+/+) ESCs. Fused cells (+PEG) or
unfused controls (PEG) were plated on puro-
mycin-resistant feeder cells in ESC medium sup-
plemented with puromycin for 12 days and stained
for alkaline phosphatase activity. Average number
of colonies from three experiments: Eed/ 3
mouse B (23 ± 11), Eed+/+ 3 mouse B (1945 ±
998).
(E) Oct4 expression, detected by immunofluore-
sence labeling (green), is retained by hybrid clones
generated from fusing Eed+/+ ESCs with mouse
B cells, but is not expressed by hybrid clones
generated from fusing Eed/ ESCs with mouse
B cells. Actin (red) staining is shown as a control.
Scale bars represent 50 mm.
See also Figure S1 and Table S1.
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ESCs Require Polycomb to Dominantly Reprogramthis approach showed that the ability of ESCs to successfully
reprogram somatic cells requires the expression of Oct4 (Pereira
et al., 2008), a factor that is required for induced pluripotent stem
cell (iPSC)-based reprogramming (Takahashi and Yamanaka,
2006; Yamanaka, 2009). Here, we show that mouse ESC lines
conditionally depleted of PRC1 or PRC2 components fail to
reprogram human B cells within heterokaryons, being unable
to induce the successful remodeling of differentiated nuclei.
This defective reprogramming is functionally dominant over
wild-type, implying that misexpression of PRC target genes by
ESCs actively interferes with their reprogramming capacity.
RESULTS
Human B Lymphocytes Are Reprogrammed by Mouse
ESCs, ECCs, and EGCs
Heterokaryon assays in which human differentiated cells are re-
programmed by mouse ESCs have been used to study success-548 Cell Stem Cell 6, 547–556, June 4, 2010 ª2010 Elsevier Inc.ful reprogramming and to define the factors required for this
dominant conversion (Blau et al., 1985; Tada et al., 2001; Terra-
nova et al., 2006). When fused with human B lymphocytes,
mouse ESCs rapidly induce the expression of human pluripo-
tency-associated genes (Pereira et al., 2008). Conversion
requires mouse Oct4 (Pereira et al., 2008) and studies in hybrids
suggest that ESCs share this property with other Oct4-express-
ing embryonic stem cells including embryonic carcinoma (EC,
such as F9, P19) and embryonic germ (EG, such as 19G and
23G) cell lines (Do et al., 2007; Tada et al., 1997, 2001). Here,
successful reprogramming was judged by qRT-PCR with
primers selective for humanOCT4, NANOG, CRIPTO, DNMT3B,
SOX2, TLE1, TERT, and REX1, and expression was monitored
from 0 to 3 days after cell fusion (Figures 1A and 1B; Figures
S1A and S1B). Each of the ESC, ECC, and EGC lines induced
pluripotency-associated gene expression by human B cells,
albeit with slight variation (Figure 1B, middle and lower panels).
For example, fusion of B lymphocytes with P19 induced higher
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ESCs Require Polycomb to Dominantly Reprogramlevels of human SOX2 expression (and less REX1) than with F9,
OS25, and E14tg2A cells in keeping with the idea that P19
preferentially differentiate toward neuronal lineages (Jones-Ville-
neuve et al., 1983) and ECCs have a narrower range of lineage
potential than ESCs (Chambers and Smith, 2004). Reprogram-
ming by 19G and 23G EGCs (Tada et al., 1998) was generally
less efficient (Figure 1B; Figure S1B) and induction of TERT
and REX1, a gene that is downregulated upon mouse epiblast
formation (Pelton et al., 2002), was not detected. No obvious
correlation between the magnitude of gene expression by
parental lines and the subsequent initiation of human genes
in heterokaryons was evident (data not shown). These results
suggested that although subtle differences in reprogramming
reflect the developmental origin of individual lines, all pluripotent
stem cell lines tested here shared the capacity to dominantly
reprogram.
ESCs that Lack PRC2 Activity Fail to Efficiently
Reprogram
To determine whether PRC2 activity is important for reprogram-
ming, we fused human B cells to mouse ESC lines that lacked
individual PRC2 components. Eed-deficient and Suz12-deficient
ESC lines were unable to induce the expression of most human
pluripotency-associated genes upon fusion with human lympho-
cytes (Figure 1C), in contrast to matched parental and heterozy-
gous controls (Figures S1C–S1F). ESCs that lacked H3K27me2/
me3 by virtue of loss of Eed (Figure S1C) or Suz12 (Figure S1E)
induced the partial expression of human OCT4 (and either
TLE1 or DNMT3B), but not other human pluripotency markers
(Figure 1C; Figures S1D and S1F). To determine whether this
failure of PRC2-deficient ESCs to efficiently reprogram human
B cells reflects a specific requirement for PRC2-mediated
repression, we tested the reprogramming capacity of ESCs
deficient in either Jarid2 (a noncatalytic component of PRC2)
(Landeira et al., 2010; Li et al., 2010; Pasini et al., 2010; Peng
et al., 2009; Shen et al., 2009) or other chromatin-remodeling
components (Figure 1C, middle and right panels; details in Table
S1). ESCs genetically deficient for factors involved in DNAmeth-
ylation (Dnmt1/, Dnmt3a/b/), histone 3 lysine 4 methylation
(Mll/), histone 3 lysine 9 methylation (G9a/), RNA interfer-
ence (Dicer/), or that lacked Jarid2 (Jarid2/), retained the
ability to successfully reprogram human B cells at levels compa-
rable with parental wild-type ESCs.
To confirm that Eed-deficient ESCs are unable to reprogram
lymphocytes, we performed hybrid analysis. Mouse B cells
(PuroR) were fused to either wild-type or Eed-deficient ESCs
and hybrids were cultured for 12 days in the presence of puro-
mycin. Reprogrammed colonies, visualized by alkaline phospha-
tase staining, were abundant in fusions performed with Eed+/+
ESCs but very rare in fusions with Eed/ ESCs (Figure 1D),
and these colonies failed to express Oct4 protein (Figure 1E;
Figure S1G). Reprogramming by wild-type ESCs was confirmed
by the re-expression of GFP in hybrids formed with mouse B
cells carrying an Oct4-GFP transgene (Figure S1H). To test
whether this defect is ESC specific, we fused wild-type mouse
ESCs (Hprt/) with either Ezh2flx/flx or Ezh2/ T cells, and we
cultured hybrids for 12 days in HAT-containing media. The
number of reprogrammed colonies was similar with wild-type
and Ezh2-deficient lymphocytes (26 versus 13, respectively)(Figure S1I), so our data suggest that ESCs selectively
require PRC2 activity to induce pluripotent conversion of
lymphocytes.
Conditional Loss of PRC2 or PRC1Ablates the Dominant
Reprogramming Capacity of ESCs
Because long-term growth of ESCs in the absence PRC2 results
in inappropriate upregulation of many important transcription
factors andmay therefore result in additional (i.e., non-PRC2 tar-
geted) changes, we confirmed these finding with ESC lines that
are inducible null for the catalytic component of PRC2, Ezh2.
ESCs were derived from conditional Ezh2 knockout mice (Su
et al., 2003). Clone Ezh2-1.3 carries a tamoxifen-inducible condi-
tional Ezh2mutation on both endogenous alleles and is progres-
sively depleted of Ezh2 protein after the addition of tamoxifen
(Figure S2A). Loss of Ezh2 resulted in loss of H3K27me3 (and
reduced H3K27me2/me1) at 96 hr after tamoxifen addition,
without consequent changes in either ESC self-renew or the effi-
ciency of PEG-mediated cell fusion (data not shown). The re-
programming capacity of Ezh2-depleted ESCs was severely
impaired and several genes were either not induced (NANOG,
REX1, TERT) or only partially induced (CRIPTO, OCT4) (Fig-
ure 2A, upper panel; Figure S2B). Long-term removal of Ezh2
(D/D) also resulted in compromised reprogramming, although
low levels of human NANOG, CRIPTO, and OCT4 transcripts
were detected, consistent with reports that Ezh1 can com-
pensate for Ezh2 deficiency (Shen et al., 2008). Interestingly,
silencing of human lymphoid-specific genes (CD19, CD45, and
CD37) was unaffected by Ezh2 depletion (Figure 2A, lower
panel), suggesting that ESCs require PRC2 selectively for acti-
vating pluripotency-associated genes during reprogramming.
To test whether the PRC1 activity was also required for
reprogramming, we examined ESCs that were conditional null
for Ring1A/B. Clone ES-ERT2 is homozygous null for the PRC1
component Ring1A and carries two tamoxifen-inducible condi-
tional knockout Ring1B alleles. Accordingly, after tamoxifen
addition, ES-ERT2 cells display a global reduction in H2A ubiq-
uitylation and Ring1B expression, while overall levels of PRC2
proteins and trimethylated H3K27 remain largely unaffected
(Endoh et al., 2008; Stock et al., 2007). ESCs lacking PRC1 did
not successfully reprogramhumanB cells. As shown in Figure 2B
and Figure S2C, tamoxifen pretreatment of ES-ERT2 cells
resulted in the failure to induce REX1 and TERT and impaired
induction of NANOG and CRIPTO, although silencing of human
lymphoid genes was again unaffected.
Reconstitution of Eed in Eed-Deficient ESCs Restores
Reprogramming Activity
To validate that the reprogramming capacity of ESCs was
dependent on PRC1/2, we rescued Eed null ESCs (clone B1.3)
by transfecting a 180 kb BAC clone carrying the entire Eed
locus. As anticipated, wild-type ESCs and stable transfectants
expressed Eed protein isoforms and H3K27me3 as detected
by western blotting (clone B1.3BAC; Figure 3A). ESCs lacking
Eed (B1.3Neo) or after Eed reconstitution (B1.3BAC) were sepa-
rately fused to hB-lymphocytes and their reprogramming
capacity compared. Restoration of Eed rescued the reprogram-
ming capacity of ESCs (Figure 3B, compare solid and open bars;
Figure S3).Cell Stem Cell 6, 547–556, June 4, 2010 ª2010 Elsevier Inc. 549
Figure 2. PRC2 or PRC1 Function Is Required for
Reprogramming to Pluripotency
Ezh2-1.3 (A) and ES-ERT2 (B) cells containing the Ezh2 and
Ring1B conditional alleles, respectively, untreated (flx/flx,
black bars) or treated with 800 nM tamoxifen for 24–96 hr
(Tmx 24-96) were fused to human B lymphocytes. ESCs
depleted long-term of Ezh2 (D/D, white bars) were included
as controls. Successful reprogramming was judged by the
expression of human OCT4, NANOG, CRIPTO, and REX1
transcripts, detected by qRT-PCR 3 days after cell fusion.
Expression of human lymphocyte-specific genes (CD19,
CD45, and CD37) declined after heterokaryon formation, as
compared with levels before fusion (Ctrl). Data were normal-
ized to human GAPDH expression. Error bars indicate the
SD of four independent experiments. See also Figure S2.
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ESCs Require Polycomb to Dominantly ReprogramCompromised Reprogramming by PRC2 Mutant ESCs Is
Not due to a Deficit in Known Reprogramming Factors
To examine whether PRC2-deficient ESCs fail to efficiently repro-
gram human B cells because they misregulate endogenous fac-
tors thathavepreviously shown tobecritical for iPS-based reprog-
ramming (Takahashi et al., 2007; Yu et al., 2007), we performed550 Cell Stem Cell 6, 547–556, June 4, 2010 ª2010 Elsevier Inc.quantitative analyses of Oct4, Nanog, Sox2, c-Myc,
Klf4, and Lin28 in different PRC2 mutant ESC lines
(Figure 4A). No major differences were detected in
expression of these transcripts in ESCs lacking
Eed, Suz12, and Ezh2, relative to matching wild-
type controls. Nevertheless, as even slight variations
in Oct4 are known to impact on ESC self-renewal,
differentiation (Niwa et al., 2000), and reprogram-
ming (Pereira et al., 2008), we engineered Eed-defi-
cient ESC lines to modestly overexpress Oct4 by
stable transfection of a Flag-tagged mOct4 trans-
gene (B1.3-Oct4, clones 1D3 and 2D1, Figure 4B).
FusionofOct4+Eed/ESC linesdid not rescue their
capacity to reprogram human B cells (Figure 4C), in
markedcontrast toESC lines that hadbeen reconsti-
tutedwith Eed (B1.3BAC1, B1.3BAC2). Thus, defec-
tive reprogramming is unlikely to be mediated by
insufficient iPSC-inducing factors.
Dominant Reprogramming
to Extraembryonic Lineages Is Not Induced
by Eed-Deficient ESCs
Several developmental regulators are derepressed
in ESCs that lack PRC2 activity and H3K27 methyl-
ation (Figure 5A; Azuara et al., 2006; Boyer et al.,
2006; Lee et al., 2006), including the transcription
factors Cdx2 and Hand1, that are required for
the specification of trophectoderm (Rossant and
Tam, 2009; Scott et al., 2000) and Gata6 and Hnf4,
which are required for the development of primitive
endoderm (Duncan et al., 1997; Rossant and Tam,
2009). We asked whether the misexpression of
these factors by PRC2-deficient ESCs (Jorgensen
et al., 2006)might result in dominant reprogramming
to extraembryonic fates as stem cells derived from
early blastocyst stages are know tobehighly related
(Santoset al., 2010). To test this possibility,we fusedEed-deficient ESCs with human lymphocytes and analyzed
the induction of CDX2, HAND1, GATA6, and HNF4 in the result-
ing heterokaryons. Whereas trophectoderm stem cells (TSCs)
and extraembryonic endoderm (XEN) stem cells dominantly
reprogrammed human B cells toward different extraembryonic
lineages (inducing CDX2/HAND1 or GATA6/HNF4 expression,
Figure 3. Reprogramming by Eed-Deficient
ESCs Is Restored by Eed Rescue
(A) Eed-deficient B1.3 ESCs were rescued by
insertion of a BAC clone that carried the Eed
gene and neomycin resistance gene. Whole-cell
lysates from these lines (B1.3BAC) and controls
(B1.3Neo andWT ESCs) were analyzed bywestern
blotting with antibodies to the Eed protein and anti-
trimethylated histone 3 lysine 27 (H3K27me3).
Equivalent protein loading is shown by Lamin B
and total H4 detection.
(B) B1.3BAC and B1.3Neo ESCs were fused
to human B lymphocytes and successful reprog-
ramming was measured by activation of human
embryonic genes 3 days after cell fusion. Data
were normalized to human GAPDH expression.
Error bars indicate the SD of 2–3 independent
experiments. See also Figure S3.
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ESCs Require Polycomb to Dominantly Reprogramrespectively), PRC2-deficient ESCs failed to induce the correct
expression of either set of markers (Figure 5B). These data
suggest that PRC2-deficient ESCs do not reprogram human
B cells toward an alternative, extraembryonic fate.
Eed-Deficient ESCs Display a Functionally Dominant
Defect in Reprogramming
The compromised reprogramming capacity of Eed-deficient
ESCs has at least two different interpretations. First, theseFigure 4. PRC2-Deficient ESCs Express Normal Levels of Reprogramm
(A) Expression of mouse Oct4, Nanog, Sox2, c-Myc, Klf4, and Lin28 trans
Suz12 (Suz12/), Ezh2 (Tmx 96; Ezh2D/D) versus their matched wild-type contro
expression and results shown are the mean and SD of three experiments.
(B)Western blotting of whole cell extracts of Eed-deficient ESCs (B1.3) and derived
or Flag antibodies. Transgene-derived Flag-Oct4 protein was detected in two clon
a control for protein loading. Approximate molecular sizes (in kD) are indicated.
(C) B1.3-Oct4 ESC clones were separately fused with human B cells and inducti
fusion. Eed-deficient ESCs transduced with an Eed containing BAC (clones B1.3
Oct4-Flag protein (clones B1.3-1D2 and B1.3-2C5) provided positive and nega
GAPDH expression and results shown are the mean and SD of three independeESCs could lack factors required for executing dominant con-
version. Second, mutant ESCs may express factors that block
the efficient reprogramming of differentiated cells. To distinguish
between these possibilities, we generated heterokaryons that
contained a human B cell nucleus, a wild-type mouse ESC
nucleus, and an Eed-deficient ESC nucleus (Figure 5C) by prel-
abeling wild-type ESCs with DiI and Eed/ ESCs with DiD.
In brief, labeled cells were mixed in a 1:1 ratio with puromycin-
resistant hB lymphocytes, fused with PEG, and cultured foring Factors
cripts by ESC lines deficient in PRC2 components (white); Eed (Eed/),
ls (black bars), analyzed by qRT-PCR. Data were normalized to mouse Gapdh
lines stably transfectedwith Oct4-Flag (clones 1D2, 1D3, 2C5, 2D1), with Oct4
es (1D3 and 2D1) at levels similar to that of endogenousOct4. Lamin B provides
on of human ESC-associated genes was monitored by qRT-PCR, 2 days after
BAC1 and B1.3BAC2) and Eed-deficient ESCs that do not express transgenic
tive controls for this analysis, respectively. Data were normalized to human
nt experiments.
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Figure 5. Defective Reprogramming of
Human B Cells by Eed-Deficient ESCs Is
Functionally Dominant
(A) Expression of developmental regulators is
upregulated in mouse ESCs that lack either Eed
(clone ESL32, red) or Suz12 (Suz12KO, white) rela-
tive to wild-type ESCs. Transcript abundance was
estimated by qRT-PCR and is expressed as fold
changeofmutant versusmatchedwild-typecontrol
line (black). Expression of non-PRC2 target genes
(Oct4, Nanog, Sox2) is shown as a control. Data
were normalized to mouse Gapdh expression and
the results are mean and SD of three experiments.
(B) The ability of Eed wild-type (ESL21, black),
heterozygous (ESL12, gray), or homozygous null
(ESL32, white) ESC lines to convert human B cells
toward extraembryonic lineages was assessed
bymonitoring the inductionof transcripts for human
trophectoderm (CDX2,HAND1) andprimitiveendo-
derm (GATA6, HNF4) over a 3 day period after
heterokaryon formation via qRT-PCR. Mouse tro-
phectoderm stem (TS, blue) and primitive endo-
derm stem (XEN, green) cell lines were used as
positive controls in the analysis. Data were normal-
ized to human GAPDH expression and the results
are mean and SD of two experiments.
(C) Strategy used to generate experimental trinucleate heterokaryons. Wild-type (ES WT) and Eed-deficient (ES Eed) cells were separately labeled with Dil or DiD
membranedyes, respectively, and fusedwithpuromycin-resistant humanBcells (hBPuror). 2 daysafter culture inpuromycin,double (Dil/DiD) labeledheterokaryons
were isolated by FACS sorting and successful reprogramming was estimated by qRT-PCR for the induction of human gene expression. Trinucleate heterokaryons
containingpairs ofwild-typeESCs (white) or pairs ofEed/ESCs (red) provide controls for this analysis.Datawere normalized tohumanGAPDH expression and the
results are mean and SD of three independent experiments. See also Figure S4.
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karyons were purified by FACS sorting. Successful reprogram-
ming was judged by the induction of human OCT4, NANOG,
CRIPTO, DNMT3B, TLE1, and TERT transcripts via quantitative
RT-PCR. Heterokaryons containing Eed-deficient nuclei (red-
white histogram, Figure 5C) expressed low levels of each of
these genes as compared with fusions that contained either a
single (not shown) or a pair of (open histogram, Figure 5C)
wild-type nuclei. Mouse Oct4, Nanog, Sox2, c-Myc, Klf4, Lin28
transcript expression was unaffected (Figure S4A) and served
as a control in these experiments. These data argue that
Eed-deficient ESCs do not simply lack factors required for
reprogramming—because provision of a functionally competent
(wild-type) nucleus did not restore reprogramming. Rather, Eed-
deficient ESCs were functionally dominant over their wild-type
counterparts, so PRC2 may be required to repress endogenous
expression of genes that interfere with reprogramming. Attempts
to define these PRC2 target genes examined 13 genes selected
from transcriptome analyses of ESCs lacking Eed, Suz12, or
Ezh2 (Figures S4B and S4C), but despite achieving efficient
knockdown of candidate genes alone, or in combination, we
were unable to fully restore reprogramming potential in Eed-defi-
cient ESCs (Figure S4D).
Eed-Deficient ESCs Fail to Induce HP1a Redistribution
and H3S10 Phosphorylation in Reprogrammed
Lymphocytes
Previous studies have shown that reprogramming can result in
profound changes in the nuclear volume and chromatin organi-
zation of differentiated nuclei (Pereira et al., 2008; Terranova
et al., 2006). We examined whether PRC2-deficient ESCs induce552 Cell Stem Cell 6, 547–556, June 4, 2010 ª2010 Elsevier Inc.similar changes in heterokaryons formed with human B cells.
Mouse (ESC-derived) Oct4 protein was translocated into human
nuclei with similar kinetics irrespective of whether wild-type or
Eed-deficient ESCs were used as fusion partners (Figure 6A,
arrowdenotes human nuclei, and Table S2).Weobserved a rapid
increase in nuclear size and changed architecture in human
lymphocytes upon heterokaryon formation, to resemble human
ESCs (Figures 6A and 6B). Eed-deficient ESCs induced similar
changes in the volume (Figure 6B) and redistribution of nucleoli
in lymphocyte-derived nuclei (Figure 6C; Figures S5A–S5C), as
induced by wild-type controls. In contrast, Eed-deficient ESCs
did not induce a redistribution of HP1a (from punctate to diffuse)
and increased H3S10 phosphorylation, which are hallmark
features of human ESCs and lymphocytes reprogrammed with
wild-type ESCs (Figures 6D and 6E). Similar chromatin reorgani-
zation has recently been reported to occur upon reprogramming
via nuclear transfer (Murata et al., 2010). HP1a recruitment is
known to bemodulated by Aurora B kinase-mediated phosphor-
ylation of H3Ser10 (Fischle et al., 2003) and by JAK2 signaling
(Dawson et al., 2009). Our data suggest a novel mechanistic
link between these chromatin events and Eed-dependent
reprogramming.
DISCUSSION
Here we show that ESCs, EGCs, and ECCs share the ability to
efficiently reprogram human lymphocytes in heterokaryons and
that this property is dependent on Polycomb repressor activity.
The deletion of individual PRC1 or PRC2 members (Eed,
Suz12, Ezh2, and Ring1A/B) that repress the expression of
developmental regulators in ESCs abolishes the capacity of
Figure 6. Impaired Chromatin Reorganization of Human B Cells
Induced by Eed-Deficient ESCs
(A) ESC-derived Oct4 protein was detected (anti-Oct4, green) within human
nuclei (arrows) 12 hr postfusion with mouse Eed-deficient (Eed/) or wild-
type (Eed+/+) ESCs. Oct4 influx was detected in a similar proportion of human
nuclei (percentage values shown in white) in both sets of heterokaryons.
Human and mouse nuclei were distinguished on the basis of DAPI (blue) stain-
ing patterns (mouse punctate, human diffuse). Actin labeling (red) was used to
delineate individual heterokaryons.
(B) The volume of human B cell (hB) nuclei before (0 hr) and 24 hr after (24 hr)
heterokaryon formation with either Eed-deficient (Eed/) or wild-type (Eed+/+)
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ESCs Require Polycomb to Dominantly ReprogramESCs to induce reprogramming. Eed-deficient mouse ESCs are
themselves self-renewing, pluripotent, and can contribute to the
three germ layers in vivo and in vitro (Chamberlain et al., 2008),
so our data show that pluripotency and reprogramming function
can be dissociated.
We demonstrate that Polycomb-mediated gene repression is
critical for ESCs to actively convert differentiated cells to pluripo-
tency. Surprisingly, defective reprogramming by PRC2-null
ESCs was not restored in heterokaryons supplemented with
wild-type ESC nuclei, showing that the reprogramming defect
is functionally dominant. A requirement for PRC2 in reprogram-
ming is consistent with previous studies in cloned mouse
embryos (Zhang et al., 2009) and iPSCs (Mikkelsen et al.,
2008), showing that failed or partially reprogrammed cells lack
PRC2-dependent H3K27me3. Furthermore, recent iPSC studies
with mouse lymphocytes and fibroblasts have suggested that
inappropriate expression of some lineage-specific genes can
impede reprogramming. For example, successful reprogram-
ming of mouse B cells requires silencing of the B cell-specific
factor Pax5 (Hanna et al., 2008; Xie et al., 2004). Reactivation
or incomplete repression of lineage-specifying factors is also
postulated to interfere with the establishment of core pluripo-
tency networks because transient silencing of interfering fac-
tors significantly improves reprogramming efficiency (Mikkelsen
et al., 2008). In this respect, reports that ESCs contain at least
two types of bivalent domains (targeted by PRC2 only or by
both PRC1 and PRC2) may be informative because PRC1-posi-
tive domains are enriched for genes encoding transcription
factors that specify developmental fate (Ku et al., 2008). It is
conceivable that repression of these targets in ESCs is particu-
larly critical for reprogramming.
Interestingly, we show here that Jarid2-null ESCs are fully
competent in reprogramming assays. Although these ESCs
display variable levels of H3K27me3 (Li et al., 2010; Pasini
et al., 2010; Peng et al., 2009; Shen et al., 2009), they do not
show a genome-wide upregulation of PRC2 target genes (char-
acteristic of Eed, Suz12, Ezh2, or Ring1A/B-depleted ESCs) and
there is evidence that Jarid2 is not required for PRC2-mediated
repression (Landeira et al., 2010). Taken together, our studies
therefore suggest that pluripotent cells require active PcG-medi-
ated repression of lineage-specifying factors to efficiently con-
vey multilineage potential during reprogramming. Whether addi-
tional properties of PRC2, including the recruitment of RBP2
(H3K4 demethylase), to target genes in ESCs (Pasini et al.,
2008) is important for reprogramming, awaits investigation.
In Drosophila melanogaster, downregulation of several PcG
proteins occurs in regenerating leg disc cells and transdetermi-
nation of leg-to-wing is enhanced in PcG heterozygous mutantESCs was compared with human ESCs (hESC, H1 cell line). Nuclear volume
was calculated as described in the Experimental Procedures, the volume of
mouse nuclei before and after heterokaryon formation provides a control.
Data shown are the mean and SD of 50–75 determinations per sample.
(C–E) The number of nucleoli (C), distribution of HP1a (D), and presence of
H3S10ph (and H3K9me3) (E) within human B nuclei before (hB) and 24 hr after
fusion with Eed-deficient or wild-type mouse ESCs was assessed by immuno-
fluorescence via B23 antibody (red, nucleoli arrowed), anti-HP1a (green), and
anti-H3S10ph/H3K9me3 (red). Human nuclei were identified via DAPI staining
(blue) and are marked by a dashed line. Human ESCs (cell line H1) are shown
as controls. Scale bars represent 10 mm. See also Figure S5 and Table S2.
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ESCs Require Polycomb to Dominantly Reprogramflies (Lee et al., 2005). Downregulation of PcG proteins is also
observed in regenerating skin in the mouse (Shaw and Martin,
2009), suggesting that reduced PcG protein levels may
encourage lineage plasticity and enhance transdetermination
(Lee et al., 2005; McClure et al., 2008). In view of these findings,
it is possible that Polycomb proteins have different roles in undif-
ferentiated versus somatic cells. Alternatively, the high ‘‘tran-
scriptional noise’’ that results from global PcG-mediated gene
derepression in ESCs (Chi and Bernstein, 2009) could be
contributing to the poor reprogramming capacity of PRC2-null
ESCs. However, this is unlikely to be the sole cause of the
reprogramming defect because ESCs that lack Dicer, a factor
that is critical for the global regulation of small RNAs (Cobb
et al., 2005; Murchison et al., 2005), reprogram human B cells
efficiently. Likewise, although recent studies have shown that
the induction of senescence is a critical roadblock for successful
reprogramming via iPS (reviewed in Krizhanovsky and Lowe,
2009), we show that levels of p53, p21, and p16 are not appre-
ciably changed when comparing wild-type or Eed-deficient
ESCs or heterokaryons derived from them (Figure S5D) and
that overexpression of p16 (a PRC2-target) by ESCs does not
inhibit reprogramming (Figures S5E and S5F). This suggests
that senescence induction is unlikely to be the cause of PRC2-
null reprogramming defects.
In summary, here we show that Polycomb-mediated repres-
sion is required by mouse ESC lines to direct the conversion of
differentiated cells toward pluripotency. ESCs lacking Eed
induced rapid changes in the volume and architecture of differ-
entiated human nuclei, but failed to direct the redistribution of
HP1a, increased phosphorylation of H3S10, and to induce
pluripotent gene expression that underlies successful reprog-
ramming. Our results support the view that reprogramming is
multistep and define Polycomb-dependent as well as Poly-
comb-independent events associated with the acquisition of
a lineage-plastic state. Collectively, these studies show that
the pluripotent and reprogramming capacities of ESCs can be
mechanistically ‘‘uncoupled’’ and provided compelling new evi-
dence that Polycomb-mediated gene repression is critical for
establishing pluripotency.EXPERIMENTAL PROCEDURES
Cell Culture
EBV-transformed hB clones were maintained in RPMI supplemented with
10% fetal calf serum (FCS, PAA Laboratories Gmbh, Pasching, Austria),
2 mM L-glutamine, and antibiotics (10 mg/ml penicillin and streptomycin).
Abelson transformed mouse B cell lines were grown in RPMI supplemented
with 20% FCS, nonessential amino acids, L-glutamine, 50 mM 2-mercaptoe-
thanol, antibiotics, and IL-7 (5 ng/ml; R&D systems, Minneapolis, MN).
Mouse ESC, EGC, and ECC lines were maintained on either irradiated mouse
embryonic fibroblast (MEFs) feeder layers or 0.1% gelatin-coated surfaces
with KO-DMEM medium,10% FCS, 5% knockout serum replacement (Invi-
trogen), nonessential amino acids, L-glutamine, 2-mercaptoethanol, antibi-
otics, and 1000 U/ml of leukemia inhibitory factor (ESGRO-LIF, Chemicon/
Millipore). 4-hydroxy-tamoxifen (800 nM, Sigma) or puromycin (1 mg/ml,
Sigma) was added to the cultures where indicated. Human ESC line H1
was cultured in medium conditioned by mitotically inactivated MEFs supple-
mented with 8 ng/ml bFGF (Peprotech, London, UK) on matrigel-coated
plates, as previously described (Xu et al., 2001). Cells were routinely
passaged at a 1:3 dilution by treatment with 200 U/ml collagenase IV
(Invitrogen).554 Cell Stem Cell 6, 547–556, June 4, 2010 ª2010 Elsevier Inc.Generation of Transgenic Cell Lines
Eed-deficient ESCs (B1.3 clone) were transfected with a bacterial artificial
chromosome (BAC, RP23-370F10), containing approximately 185 kb (nucleo-
tides 97076839-97260535) of the forward DNA strand of mouse chromosome
7. In this clone, the chloramphenicol acetyltransferase (CAT) gene that was
replaced with a neomycin resistance cassette from plasmid pL452 (NCI, Fred-
erick, MD). B1.3-Oct4 ESC lines were generated by stable transfection of Flag-
tagged mouse Oct4 in Eed-deficient ESCs (B1.3 clone). Mouse Oct4 cDNA
was cloned in the pDFLAG-cDNAIII vector (Invitrogen). The cDNA, including
two flag sequences at the 50 end, was excised and subcloned into a suitable
vector for expression in ESCs (pCBA), with expression driven by the chicken
b-actin promoter (Pereira et al., 2008). G418 selection (400 mg/ml; Invitrogen)
was applied 48 hr after transfection and resistant clones were screened by
western blot. Human and mouse B cells were transduced with a replication
incompetent retroviral vector carrying a puromycin resistance gene and
selected (1 mg/ml puromycin, Sigma) 48 hr after transfection.
Experimental Heterokaryons
Heterokaryons were generated by fusing mouse ESCs and human B lympho-
cytes with 50% polyethylene glycol (pH 7.4) (PEG 1500; Roche Diagnostics,
Mannheim, Germany) as described previously (Pereira and Fisher, 2009).
Mouse ESCs and hB lymphocytes were labeled with Vibrant 1,10-diocta-
decyl-3, 3, 30, 30 tetramethylindodicarbocyanine (DiD) and 1,10-dioctadecyl-
3, 3, 30, 30-tetramethylindocarbocyanine perchlorate (DiI) cell labeling solutions
(Molecular Probes, Eugene, OR), respectively. Cells were resuspended at 13
106 cells/ml in DMEM and labeled with 5 ml/ml of dye at 37C, 15 min. ESCs
and hB were then mixed in a 1:1 ratio, washed, and fused with PEG (50%,
at 37C over 1 min before dilution). Cells were washed and cultured in ES
media at 0.5 3 106 cells/cm2. To eliminate unfused human B cells, Ouabain
(105 M; Sigma) was added to the medium 4 hr after cell fusion. Proliferating
ESCs were eliminated by the addition of 105 M Ara-C (Cytosine b-D arabino
furanoside; Sigma) 4–6 hr after fusion and then removed after 16 hr. Trikaryons
were generated by labeling Eed-deficient ESCs and wild-type ESCs with DiD
and DiI, respectively, andmixing with PuroR human B cells in 1:1:1 ratio, before
cell fusion. Puromycin and Ouabain were added 6 hr after cell fusion to select
for heterokaryons. After 2 days of culture, DiD+DiI+ cells were sorted and
analyzed. For FACS analysis, a FACScalibur (BD Biosciences) with CellQuest
software was used. FACS purification was performed with a FACSAria cell
sorter.
Quantitative RT-PCR Analysis
RNA extraction was performed with RNA-BEE reagent (Tel-Test Inc., Friends-
wood, TX) and residual DNA was eliminated with the DNA-free kit (Ambion,
Austin, TX). 3 mg of total RNA was then reverse transcribed with Superscript
First-Strand Synthesis system (QIAGEN) with oligo (dT)12-18 (Invitrogen).
cDNAs of interest were then quantified with real-time qPCR amplification.
Real-time PCR analysis was carried out on aOpticon DNA engine with Opticon
Monitor software (MJ Research Inc., Waltham, MA), running the following
program: 95C for 15 min, then 40 cycles of 94C for 15 s, 60C for 30 s,
72C for 30 s, followed by plate-read. PCR reactions included 23 Sybr-Green
PCRMastermix (QIAGEN), 300 nMprimers, and 2 ml of template in a 35 ml reac-
tion volume. Assays were performed in triplicate and data normalized accord-
ing to GAPDH expression. Primers were designed with Primer Express soft-
ware (Applied Biosystems) and pretested for the selective detection of
human transcripts (and not mouse). Analysis of qPCR data was performed
with the Opticon Monitor 3 software and the relative abundance of sequences
was calculated with the DC(T) method (Pereira and Fisher, 2009).
Immunofluorescence and Western Blot Analysis
Immunofluorescence was performed as previously described (Terranova
et al., 2006) with DAPI staining to distinguish mouse and human nuclei. Indi-
vidual cells were delineated by F-actin staining (Phalloidin; A12380, Molecular
Probes). Mouse monoclonal anti-Oct4 (611202; BD Biosciences, San Jose,
CA), mousemonoclonal anti-HP1a antibody (MAB3584, Millipore, Lake Placid,
NY), rabbit polyclonal anti-histone H3S10 phosphorylation (and H3K9me3)
antibody (ab5819, Abcam, Cambridge, UK), and rabbit polyclonal anti-B23
(sc-5564; Santa Cruz Biotechnology Inc., Santa Cruz, CA) were used at
1:100 dilution. Secondary antibodies conjugated with fluorochromes were
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ESCs Require Polycomb to Dominantly Reprogrampurchased from Molecular Probes and used at 1:400 dilution. Samples were
analyzed on a Leica TCS SP5 confocal microscope and processed with Leica
software and Adobe Photoshop. To estimate nuclear volumes, z-stacks
(0.5 mm distance) spanning individual nuclei were acquired. Volocity image
processing software was used for 3D reconstructions and to quantify the
nuclear volume. Nucleoli were discriminated on the basis of B23 labeling
and counted in reconstructed projections. Western blot analysis was per-
formed as previously described (Azuara et al., 2006) with goat polyclonal
anti-Oct3/4 (sc-8628; Santa Cruz Biotechnology), mouse monoclonal anti-
Flag (F3165, Sigma), mouse monoclonal anti-Eed (kindly provided by
A. Otte, University of Amsterdam, The Netherlands), rabbit polyclonal anti-
Suz12 (CS-029-050; Diagenode SA, Lie`ge, Belgium), rabbit polyclonal anti-
Ezh2 (CS-039-050; Diagenode), rabbit polyclonal anti-histone 3 lysine 27
monomethylation (07-448; Millipore), rabbit polyclonal anti-histone 3 lysine
27 dimethylation (07-452; Millipore), rabbit polyclonal anti-histone 4 lysine 20
trimethylation (07-463; Millipore). As loading controls, blots were incubated
with anti-Lamin B goat polyclonal (sc-6216; Santa Cruz Biotechnology), rabbit
polyclonal anti-histone 3 C terminus (ab1791; Abcam), and/or mouse mono-
clonal anti-histone 4 C terminus antibody (ab31827, Abcam). Each lane con-
tained 20 mg total protein. For alkaline phosphate assays, hybrid colonies
12 days after cell fusion were stained with alkaline phosphatase assay kit.
Animal Procedures
Animals were housed and handled in accordance with the guidelines of the
Imperial College subcommittee for animal research and the regulations set
out by the British home office.
SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures and two tables and can be
found with this article online at doi:10.1016/j.stem.2010.04.013.
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